Cindy Dodd

Cindy Dodd holds extensive experience in financial planning and analysis (FP&A) across multiple prominent organizations. Currently serving as Senior Director, FP&A at Kronos Bio since September 2024, Cindy previously held senior roles at Senti Biosciences and Jazz Pharmaceuticals, culminating in a wealth of expertise in R&D finance. Earlier positions include Finance Manager at Dermira, Inc., and various financial analyst roles at Genentech and Pacific Gas and Electric Company, where Cindy contributed to significant budget management and financial reporting initiatives. Additionally, foundational experience was gained at State Street Bank and Franklin Templeton Investments, focusing on trade operations and fund accounting. Cindy Dodd earned a Bachelor of Science in Managerial Economics and a Master's in Business Administration with a concentration in Accounting/Finance from the University of California, Davis.